Aravind Cherukuri

Aravind Cherukuri practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Aravind Cherukuri's NPI, 1831682707, was assigned on June 14, 2018. Aravind Cherukuri holds Pennsylvania license MT216522.

Aravind Cherukuri's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Aravind Cherukuri's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Aravind Cherukuri is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Aravind Cherukuri to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Aravind Cherukuri practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Aravind Cherukuri's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Aravind Cherukuri is licensed in Pennsylvania.

CMS data shows 88 Medicare services from Aravind Cherukuri across 1 procedure code in 2024, for 44 Medicare patients. Medicare paid $5,158 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 44 Medicare patients who saw Aravind Cherukuri in 2024. The largest group is under 65, with 24 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. Their average risk score is 7.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Aravind Cherukuri's median patient age at 58, with 30% women.

In 2024, Aravind Cherukuri wrote 23 Medicare Part D claims. 96% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $1,876 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Aravind Cherukuri for performance year 2024, reported as part of a group. Aravind Cherukuri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Aravind Cherukuri, published from 2018 to 2025. 2018 was the busiest year, with 2. The most frequent topics are Graft Rejection, Kidney Transplantation and B-Lymphocytes, Regulatory. Aravind Cherukuri has published most often in Curr Opin Organ Transplant. Aravind Cherukuri's most frequent co-authors are Sundaram Hariharan, MD, Fadi George Lakkis, MD and Rajil B. Mehta.

CMS Open Payments shows 4 general payments to Aravind Cherukuri from 2 drug and device companies from 2019 to 2024. Travel and lodging make up the largest share, 49% of the total. Merck Sharp & Dohme Corporation paid the most, $1,532.